Cargando…

Early anterior cingulate involvement is seen in presymptomatic MAPT P301L mutation carriers

BACKGROUND: PET imaging of glucose metabolism has revealed presymptomatic abnormalities in genetic FTD but has not been explored in MAPT P301L mutation carriers. This study aimed to explore the patterns of presymptomatic hypometabolism and atrophy in MAPT P301L mutation carriers. METHODS: Eighteen a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Clarke, Mica T. M., St-Onge, Frédéric, Beauregard, Jean-Mathieu, Bocchetta, Martina, Todd, Emily, Cash, David M., Rohrer, Jonathan D., Laforce, Robert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7876816/ https://www.ncbi.nlm.nih.gov/pubmed/33568215 http://dx.doi.org/10.1186/s13195-021-00777-9

Ejemplares similares

Altered Anterior Insular Metabolic Connectivity in Asymptomatic MAPT P301L Carriers
por: Chu, Min, et al.
Publicado: (2023)

[(18)F]Flortaucipir PET Across Various MAPT Mutations in Presymptomatic and Symptomatic Carriers
por: Wolters, Emma E., et al.
Publicado: (2021)

Disease-related cortical thinning in presymptomatic granulin mutation carriers
por: Borrego-Écija, Sergi, et al.
Publicado: (2020)

Cerebral blood flow in presymptomatic MAPT and GRN mutation carriers: A longitudinal arterial spin labeling study()
por: Dopper, Elise G.P., et al.
Publicado: (2016)

Presymptomatic and early pathological features of MAPT-associated frontotemporal lobar degeneration
por: Giannini, Lucia AA, et al.
Publicado: (2023)

White matter hyperintensities are seen only in GRN mutation carriers in the GENFI cohort
por: Sudre, Carole H., et al.
Publicado: (2017)

Long-Term Hydromethylthionine Treatment Is Associated with Delayed Clinical Onset and Slowing of Cerebral Atrophy in a Pre-Symptomatic P301S MAPT Mutation Carrier
por: Bentham, Peter, et al.
Publicado: (2021)

Ventricular volume expansion in presymptomatic genetic frontotemporal dementia
por: Tavares, Tamara P., et al.
Publicado: (2019)

Defining the presymptomatic phase of frontotemporal dementia
por: Russell, Lucy L., et al.
Publicado: (2023)

Rates of lobar atrophy in asymptomatic MAPT mutation carriers
por: Chen, Qin, et al.
Publicado: (2019)

A panel of CSF proteins separates genetic frontotemporal dementia from presymptomatic mutation carriers: a GENFI study
por: Bergström, Sofia, et al.
Publicado: (2021)

Accumulation of m(6)A exhibits stronger correlation with MAPT than β-amyloid pathology in an APP(NL-G-F) /MAPT(P301S) mouse model of Alzheimer’s disease
por: Jiang, Lulu, et al.
Publicado: (2023)

Accumulation of m(6)A exhibits stronger correlation with MAPT than β-amyloid pathology in an APP(NL-G-F) /MAPT(P301S) mouse model of Alzheimer’s disease
por: Jiang, Lulu, et al.
Publicado: (2023)

Presymptomatic studies in genetic frontotemporal dementia
por: Rohrer, J.D., et al.
Publicado: (2013)

The role of MAPT gene in Chinese dementia patients: a P301L pedigree study and brief literature review
por: He, Shuang, et al.
Publicado: (2018)

Functional network resilience to pathology in presymptomatic genetic frontotemporal dementia
por: Rittman, Timothy, et al.
Publicado: (2019)

Elevated 4R‐tau in astrocytes from asymptomatic carriers of the MAPT 10+16 intronic mutation
por: Setó‐Salvia, Núria, et al.
Publicado: (2021)

Anomia is present pre-symptomatically in frontotemporal dementia due to MAPT mutations
por: Bouzigues, Arabella, et al.
Publicado: (2022)

Characterizing the Clinical Features and Atrophy Patterns of MAPT-Related Frontotemporal Dementia With Disease Progression Modeling
por: Young, Alexandra L., et al.
Publicado: (2021)

Altered levels of CSF proteins in patients with FTD, presymptomatic mutation carriers and non-carriers
por: Remnestål, Julia, et al.
Publicado: (2020)

Cerebral perfusion changes in presymptomatic genetic frontotemporal dementia: a GENFI study
por: Mutsaerts, Henri J M M, et al.
Publicado: (2019)

In vivo evidence for pre‐symptomatic neuroinflammation in a MAPT mutation carrier
por: Bevan‐Jones, W. Richard, et al.
Publicado: (2019)

Brain volumetric deficits in MAPT mutation carriers: a multisite study
por: Chu, Stephanie A., et al.
Publicado: (2020)

Cognitive reserve and TMEM106B genotype modulate brain damage in presymptomatic frontotemporal dementia: a GENFI study
por: Premi, Enrico, et al.
Publicado: (2017)

Two pathologically confirmed cases of novel mutations in the MAPT gene causing frontotemporal dementia
por: Shafei, Rachelle, et al.
Publicado: (2020)

Diverse, evolving conformer populations drive distinct phenotypes in frontotemporal lobar degeneration caused by the same MAPT-P301L mutation
por: Daude, Nathalie, et al.
Publicado: (2020)

Gyrification abnormalities in presymptomatic c9orf72 expansion carriers
por: Caverzasi, Eduardo, et al.
Publicado: (2019)

FDG-PET in presymptomatic C9orf72 mutation carriers
por: Popuri, Karteek, et al.
Publicado: (2021)

Longitudinal Brain Atrophy Rates in Presymptomatic Carriers of Genetic Frontotemporal Dementia
por: Poos, Jackie M., et al.
Publicado: (2022)

Metabolic alterations precede neurofilament changes in presymptomatic ALS gene carriers
por: Dorst, Johannes, et al.
Publicado: (2023)

Apathy in presymptomatic genetic frontotemporal dementia predicts cognitive decline and is driven by structural brain changes
por: Malpetti, Maura, et al.
Publicado: (2020)

Motor Decline in Clinically Presymptomatic Spinocerebellar Ataxia Type 2 Gene Carriers
por: Velázquez-Perez, Luis, et al.
Publicado: (2009)

Network degeneration and dysfunction in presymptomatic C9ORF72 expansion carriers
por: Lee, Suzee E., et al.
Publicado: (2016)

Viral kinetics of SARS-CoV-2 in asymptomatic carriers and presymptomatic patients
por: Kim, Seong Eun, et al.
Publicado: (2020)

COVID-19 Transmission Within a Family Cluster by Presymptomatic Carriers in China
por: Qian, Guoqing, et al.
Publicado: (2020)

Different MAPT haplotypes influence expression of total MAPT in postmortem brain tissue
por: Tauber, Christina V., et al.
Publicado: (2023)

Conformation-Dependent Oligomers in Cerebrospinal Fluid of Presymptomatic Familial Alzheimer's Disease Mutation Carriers
por: Ringman, John M., et al.
Publicado: (2012)

Single-subject classification of presymptomatic frontotemporal dementia mutation carriers using multimodal MRI
por: Feis, Rogier A., et al.
Publicado: (2018)

CSF neurofilament light concentration is increased in presymptomatic CHMP2B mutation carriers
por: Rostgaard, Nina, et al.
Publicado: (2018)

Single-subject classification of presymptomatic frontotemporal dementia mutation carriers using multimodal MRI
por: Feis, Rogier A., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_e4lrigkvjup424lj35vocvsb6j